Acusphere

Speciality pharmaceutical company developing cardiovascular drugs for the detection of coronary artery disease.

Launch date

1993

Employees

Market cap

Enterprise valuation

$3m (Public information from Sep 2024)

Lexington Kentucky (HQ)

Date	Investors	Amount	Round
-	Western Technology Investment	N/A	-
Apr 2003	Polaris Partners BancBoston Ventures Thomas Weisel Partners Audax Ventures Technology Funding HBM Healthcare Investments	$19.0m	Late VC
Oct 2003	N/A	N/A	IPO
Jul 2011	N/A	$7.5m	Early VC
Feb 2012	N/A	$2.5m	Debt
Sep 2019	N/A	$100k	Convertible
Total Funding		$26.6m

Tech stackLearn more about the technologies and tools that this company uses.

Recent News about Acusphere